PHE issues guide on sepsis in children for health visitors and school nurses

PHE issues guide on sepsis in children for health visitors and school nurses

October 10 2017 A new guide setting out information around sepsis in children has been published...

MHRA issues Drug Safety Updates for loperamide and miconazole

MHRA issues Drug Safety Updates for loperamide and miconazole

October 4 2017 The medicines regulator, the MHRA, has issued Drug Safety Updates on two...

Pregnant women are still not being informed of risks associated with sodium valproate

Pregnant women are still not being informed of risks associated with sodium valproate

September 26 2017 Almost a fifth of women with epilepsy (18%) who take sodium valproate are not...

Accu-Chek Insight insulin pumps in MHRA alert over risk of alarm failure

Accu-Chek Insight insulin pumps in MHRA alert over risk of alarm failure

September 25 2017 Users of the Accu-Chek Insight insulin pumps are being asked to check their...

Flu vaccine for 2016-17 season not considered effective in the over 65s age group

Flu vaccine for 2016-17 season not considered effective in the over 65s age group

September 6 2017 Provisional figures for vaccine effectiveness in the 2016-17 flu season have...

  • PHE issues guide on sepsis in children for health visitors and school nurses

    PHE issues guide on sepsis in children for health visitors and school nurses

    Tuesday, 10 October 2017 13:34
  • MHRA issues Drug Safety Updates for loperamide and miconazole

    MHRA issues Drug Safety Updates for loperamide and miconazole

    Wednesday, 04 October 2017 17:04
  • Pregnant women are still not being informed of risks associated with sodium valproate

    Pregnant women are still not being informed of risks associated with sodium valproate

    Tuesday, 26 September 2017 15:51
  • Accu-Chek Insight insulin pumps in MHRA alert over risk of alarm failure

    Accu-Chek Insight insulin pumps in MHRA alert over risk of alarm failure

    Monday, 25 September 2017 14:26
  • Flu vaccine for 2016-17 season not considered effective in the over 65s age group

    Flu vaccine for 2016-17 season not considered effective in the over 65s age group

    Wednesday, 06 September 2017 16:53

pills in handMay 11 2016

Initiating antiepileptic drug therapy in someone who has had a first unprovoked seizure may not always be the best option, a Cochrane review has proposed.

Initiating an antiepileptic after a single unprovoked seizure appears to reduce the risk of a subsequent seizure. High quality evidence indicated there was a lower probability of seizure at a year and at five years, and a higher probability of five-year remission of seizures, said the researchers.

However, there was no evidence that antiepileptic treatment affected the overall mortality of epilepsy, and treatment of the first seizure “was associated with a significantly higher risk of adverse events.” In addition, “there is moderate quality evidence that immediate treatment may result in more side effects than delayed treatment, but it is unclear if immediate treatment results in more side effects than placebo or no treatment.”

The findings are drawn from a review of six studies, covering data from 1,634 participants, including those who had received immediate drug treatment after their first seizure. Primary outcomes were seizure recurrence and immediate remission for five years.

Among the secondary findings were that the median time to a second seizure occurring was 736 days in the control group, and 1,165 in patients who had been initiated on treatment after their first seizure. Two of the studies had also included reporting on deaths, but showed that time to death was not different between those initiated on antiepileptics and those in the control group.

“The decision to start antiepileptic drug treatment following a first seizure still remains a controversial issue,” said the researchers. “indiscriminate treatment following a first unprovoked seizure is not warranted, since the risk of recurrence must be balanced against the likelihood to attain five-year remission during the follow-up and the possible harm of drugs given for a long-lasting period.

“Adverse events associated with antiepileptic drugs are a particular concern for children, women considering pregnancy, pregnant women, and the elderly. Therefore, the decision to start antiepileptic drug treatment following a first unprovoked seizure should be individualized and based on patient preference, clinical, legal, and socio-cultural factors.”

Links:

Cochrane review

MA Leone. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Cochrane Database of Systematic Reviews. Published online May 6 2016

Clinical News

October 20 2017 Recruitment to GP training places in Wales has meant 91% of places were filled in 2017, the Welsh Government has announced. The success means that the recruitment campaign ‘This is...
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...